Abstract
1. The interaction of intraperitoneal administration of salmon-calcitonin with opioids was studied. The study was carried out using guinea pig ileum (mu and kappa-opioid receptors), rabbit vas deferens (kappa-opioid receptors) and mouse vas deferens (delta-opioid receptors), and selective mu, delta and kappa agonists were used in the pertinent tissues. 2. The treatment with salmon-calcitonin increased, in a dose-dependent manner, the effect of U-50,488H in guinea pig ileum and rabbit vas deferens and the effects of [D-Pen2, D-Pen5] enkephalin in mouse vas deferens. 3. The treatment with analgesic doses of salmon-calcitonin enhances the in vitro effects of kappa- and delta-opioid agonists. The increase of the effectiveness of the opioid agonists may be one of the mechanisms involved on the analgesia induced by salmon-calcitonin.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
-
Analgesics / pharmacology*
-
Animals
-
Calcitonin / pharmacology*
-
Dose-Response Relationship, Drug
-
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
-
Enkephalins / pharmacology
-
Guinea Pigs
-
Ileum / drug effects
-
Ileum / physiology
-
In Vitro Techniques
-
Male
-
Mice
-
Muscle Contraction / drug effects
-
Narcotics / pharmacology*
-
Pyrrolidines / pharmacology
-
Rabbits
-
Receptors, Opioid, delta / drug effects
-
Receptors, Opioid, kappa / drug effects
-
Vas Deferens / drug effects
-
Vas Deferens / physiology
Substances
-
Analgesics
-
Enkephalins
-
Narcotics
-
Pyrrolidines
-
Receptors, Opioid, delta
-
Receptors, Opioid, kappa
-
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
-
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
-
salmon calcitonin
-
Calcitonin